Efficacy and Safety of Intrapleural Instillation of Alteplase in the Management of Complicated Pleural Effusion or Empyema
- 1 July 2007
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of Sport Medicine
- Vol. 14 (4), 341-345
- https://doi.org/10.1097/01.mjt.0000208275.88120.d1
Abstract
We investigated the efficacy and safety of intrapleural instillation of recombinant tissue plasminogen activator (Alteplase) in 120 patients with complicated pleural effusion (CPE) or empyema. These 120 patients had failed simple chest tube placement and conventional medical treatment. The patients included 52 with empyema, 41 with CPE, 10 with hemothorax, and 17 with complicated malignant pleural effusions. A total of 345 doses of Alteplase were instilled intrapleurally in these patients, with doses ranging from 10 to 100 mg daily. Most patients required 3 to 4 doses of alteplase. After Alteplase therapy, complete resolution of CPE/empyema occurred in 102 patients (85%), partial resolution in 10 patients (8%), and failure to respond in 8 patients (7%). All patients who failed to respond to Alteplase treatment had either chronic empyema or empyema associated with lung abscesses. Adverse effects of Alteplase therapy were chest pain in 7 patients (6%) and bleeding at the chest tube site in 2 patients (2%).Keywords
This publication has 12 references indexed in Scilit:
- U.K. Controlled Trial of Intrapleural Streptokinase for Pleural InfectionNew England Journal of Medicine, 2005
- Multicenter Trials of Treatment for Empyema — After All These YearsNew England Journal of Medicine, 2005
- Effect of Repeated Thoracenteses on Fluid Characteristics, Cytokines, and Fibrinolytic Activity in Malignant Pleural EffusionChest, 2003
- Medical and Surgical Treatment of Parapneumonic EffusionsChest, 2000
- Intrapleural Urokinase versus Normal Saline in the Treatment of Complicated Parapneumonic Effusions and EmpyemaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Randomised controlled trial of intrapleural streptokinase in community acquired pleural infectionThorax, 1997
- Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study.American Journal of Respiratory and Critical Care Medicine, 1997
- Do Pulmonary Radiographic Findings at Presentation Predict Mortality in Patients With Community-Acquired Pneumonia?Archives of Internal Medicine, 1996
- Treatment of loculated pleural effusions with transcatheter intracavitary urokinaseAmerican Journal of Roentgenology, 1989
- The Incidence and Clinical Correlates of Parapneumonic Effusions in Pneumococcal PneumoniaChest, 1978